Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321847772> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2321847772 endingPage "184" @default.
- W2321847772 startingPage "179" @default.
- W2321847772 abstract "Background Denosumab therapy is commonly used for the prevention of skeletal-related events in patients with bone metastasis. However, a common side effect of denosumab is hypocalcemia. Objective The aim of the study is to determine the incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis and evaluate risk factors for developing hypocalcemia. Methods This was a retrospective medication use evaluation reviewing the incidence of hypocalcemia in patients receiving outpatient denosumab for prevention of skeletal-related events at Yale–New Haven Hospital. Additionally, various risk factors were reviewed to determine their risk of developing hypocalcemia. Results As per Common Terminology Criteria for Adverse Events v4.03, of the 106 patients included in the study population, 37 (35%) patients had an incidence of hypocalcemia within 30 days of denosumab administration. Fourteen patients (13.2%) had an incidence of grade 1, 13 patients (12.3%) had an incidence of grade 2 hypocalcemia, and 7 patients (6.6%) had an incidence of grade 3 hypocalcemia. Grade 4 hypocalcemia occurred in three (2.8%) patients. Calcium supplementation did not decrease the risk of developing hypocalcemia. Patients who had one or more episodes of acute kidney insufficiency were at a higher risk of developing hypocalcemia (odds ratio = 7.5 (95% confidence interval = 1.8–36.3), p = 0.001). Conclusion This study found that the overall incidence of hypocalcemia and severe hypocalcemia was higher than reported in clinical trials. Additionally, calcium supplementation did not have an effect on incidence of hypocalcemia, while patients who experienced acute kidney insufficiency while on denosumab had a higher likelihood of developing hypocalcemia." @default.
- W2321847772 created "2016-06-24" @default.
- W2321847772 creator A5029915688 @default.
- W2321847772 creator A5039356384 @default.
- W2321847772 creator A5074441104 @default.
- W2321847772 date "2016-06-23" @default.
- W2321847772 modified "2023-09-28" @default.
- W2321847772 title "Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis" @default.
- W2321847772 cites W1967875617 @default.
- W2321847772 cites W1996589664 @default.
- W2321847772 cites W2007492985 @default.
- W2321847772 cites W2017845136 @default.
- W2321847772 cites W2035792508 @default.
- W2321847772 cites W2039750668 @default.
- W2321847772 cites W2089210384 @default.
- W2321847772 cites W2118814475 @default.
- W2321847772 cites W2150126991 @default.
- W2321847772 cites W2162430238 @default.
- W2321847772 cites W2607028219 @default.
- W2321847772 doi "https://doi.org/10.1177/1078155216628325" @default.
- W2321847772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26830549" @default.
- W2321847772 hasPublicationYear "2016" @default.
- W2321847772 type Work @default.
- W2321847772 sameAs 2321847772 @default.
- W2321847772 citedByCount "13" @default.
- W2321847772 countsByYear W23218477722016 @default.
- W2321847772 countsByYear W23218477722018 @default.
- W2321847772 countsByYear W23218477722019 @default.
- W2321847772 countsByYear W23218477722020 @default.
- W2321847772 countsByYear W23218477722021 @default.
- W2321847772 countsByYear W23218477722023 @default.
- W2321847772 crossrefType "journal-article" @default.
- W2321847772 hasAuthorship W2321847772A5029915688 @default.
- W2321847772 hasAuthorship W2321847772A5039356384 @default.
- W2321847772 hasAuthorship W2321847772A5074441104 @default.
- W2321847772 hasConcept C120665830 @default.
- W2321847772 hasConcept C121332964 @default.
- W2321847772 hasConcept C121608353 @default.
- W2321847772 hasConcept C126322002 @default.
- W2321847772 hasConcept C156957248 @default.
- W2321847772 hasConcept C2776286101 @default.
- W2321847772 hasConcept C2776541429 @default.
- W2321847772 hasConcept C2777783956 @default.
- W2321847772 hasConcept C530470458 @default.
- W2321847772 hasConcept C61511704 @default.
- W2321847772 hasConcept C71924100 @default.
- W2321847772 hasConceptScore W2321847772C120665830 @default.
- W2321847772 hasConceptScore W2321847772C121332964 @default.
- W2321847772 hasConceptScore W2321847772C121608353 @default.
- W2321847772 hasConceptScore W2321847772C126322002 @default.
- W2321847772 hasConceptScore W2321847772C156957248 @default.
- W2321847772 hasConceptScore W2321847772C2776286101 @default.
- W2321847772 hasConceptScore W2321847772C2776541429 @default.
- W2321847772 hasConceptScore W2321847772C2777783956 @default.
- W2321847772 hasConceptScore W2321847772C530470458 @default.
- W2321847772 hasConceptScore W2321847772C61511704 @default.
- W2321847772 hasConceptScore W2321847772C71924100 @default.
- W2321847772 hasIssue "3" @default.
- W2321847772 hasLocation W23218477721 @default.
- W2321847772 hasLocation W23218477722 @default.
- W2321847772 hasOpenAccess W2321847772 @default.
- W2321847772 hasPrimaryLocation W23218477721 @default.
- W2321847772 hasRelatedWork W2064471311 @default.
- W2321847772 hasRelatedWork W2275480158 @default.
- W2321847772 hasRelatedWork W2884908904 @default.
- W2321847772 hasRelatedWork W2906311539 @default.
- W2321847772 hasRelatedWork W2982889194 @default.
- W2321847772 hasRelatedWork W3155352583 @default.
- W2321847772 hasRelatedWork W4239467322 @default.
- W2321847772 hasRelatedWork W4247326581 @default.
- W2321847772 hasRelatedWork W2133641178 @default.
- W2321847772 hasRelatedWork W2186476187 @default.
- W2321847772 hasVolume "23" @default.
- W2321847772 isParatext "false" @default.
- W2321847772 isRetracted "false" @default.
- W2321847772 magId "2321847772" @default.
- W2321847772 workType "article" @default.